PT1305082E - Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca - Google Patents

Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca

Info

Publication number: PT1305082E
Authority: PT; Portugal
Prior art keywords: pain; phenyl; alkyl; enxaqueca; salvas
Prior art date: 2000-07-21

Application number

PT01952773T

Other languages

English (en)

Inventor

Richard P Shank

Carlos R Plata-Salaman

Ellen E Codd

Katherine E Rogers

Boyu Zhao

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2001-07-16

Publication date

2004-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1305082(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-16 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-09-30 Publication of PT1305082E publication Critical patent/PT1305082E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PT01952773T 2000-07-21 2001-07-16 Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca PT1305082E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21965700P	2000-07-21	2000-07-21

Publications (1)

Publication Number	Publication Date
PT1305082E true PT1305082E (pt)	2004-09-30

Family

ID=22820176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT01952773T PT1305082E (pt)	2000-07-21	2001-07-16	Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca

Country Status (28)

Country	Link
US (4)	US20020107283A1 (pt)
EP (1)	EP1305082B1 (pt)
JP (1)	JP5271473B2 (pt)
KR (1)	KR100792814B1 (pt)
CN (1)	CN1250213C (pt)
AT (1)	ATE267629T1 (pt)
AU (2)	AU7349301A (pt)
BG (1)	BG107529A (pt)
BR (1)	BR0112713A (pt)
CA (1)	CA2416819C (pt)
CZ (1)	CZ2003445A3 (pt)
DE (1)	DE60103546T2 (pt)
DK (1)	DK1305082T3 (pt)
EA (1)	EA005648B1 (pt)
ES (1)	ES2221651T3 (pt)
HU (1)	HUP0302940A3 (pt)
IL (2)	IL154052A0 (pt)
MX (1)	MXPA03000619A (pt)
MY (1)	MY127317A (pt)
NO (1)	NO330055B1 (pt)
NZ (1)	NZ523851A (pt)
PL (1)	PL365701A1 (pt)
PT (1)	PT1305082E (pt)
SK (1)	SK1962003A3 (pt)
TR (1)	TR200401511T4 (pt)
UA (1)	UA74195C2 (pt)
WO (1)	WO2002007822A2 (pt)
ZA (1)	ZA200301403B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002254015B2 (en) *	2001-02-27	2006-08-24	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in the treatment of pain
KR20040016994A (ko)	2001-07-16	2004-02-25	오르토-맥네일 파마슈티칼, 인코퍼레이티드	신경병증 통증 및 군발성 및 편두통성 두통-관련 통증의예방 또는 치료를 위해 사용하기 위한 카바메이트 화합물
ES2278035T3 (es) *	2001-07-16	2007-08-01	Ortho-Mcneil Pharmaceutical, Inc.	Compuestos de carbamato destinados a ser utilizados en la prevencion o el tratamiento del dolor neuropatico y del dolor asociado a las cefaleas agrupadas y por migrañas.
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
WO2004054608A2 (en) *	2002-12-12	2004-07-01	Agennix Incorporated	Lactoferrin in the reduction of pain
WO2006047744A2 (en) *	2004-10-26	2006-05-04	Agennix Incorporated	Compositions of lactoferrin related peptides and uses thereof
KR20080025034A (ko) *	2005-01-20	2008-03-19	얀센 파마슈티카 엔.브이.	Ｑｔ 간격 조절 방법
BRPI0710210A2 (pt)	2006-03-30	2011-05-24	Glaxomithkline Biolog S A	composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular
EA200970368A1 (ru) *	2006-10-10	2009-10-30	Янссен Фармацевтика Нв	Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) *	2013-08-22	2015-02-26	Sucampo Ag	Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
HU191549B (en) *	1984-04-11	1987-03-30	Richter Gedeon Vegyeszet	Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) *	1988-12-27	1989-09-19	Hoechst-Roussel Pharmaceuticals, Inc.	N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
JP2002502412A (ja) *	1997-06-05	2002-01-22	サノフィ−サンテラボ	５−ナフタレン−１−イル−１，３−ジオキサン誘導体、製造方法および治療用途
JP4276837B2 (ja) *	2001-02-27	2009-06-10	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	双極性障害の予防もしくは治療における使用のためのカルバメート化合物
RU2294739C2 (ru) *	2001-02-27	2007-03-10	Орто-Макнейл Фармасьютикал, Инк.	Производные карбамата для применения для предупреждения или лечения расстройств движений
JP4276841B2 (ja) *	2001-02-27	2009-06-10	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	精神病性障害の予防もしくは治療における使用のためのカルバメート化合物

2001
- 2001-07-16 CZ CZ2003445A patent/CZ2003445A3/cs unknown
- 2001-07-16 DE DE60103546T patent/DE60103546T2/de not_active Expired - Lifetime
- 2001-07-16 UA UA2003010559A patent/UA74195C2/uk unknown
- 2001-07-16 HU HU0302940A patent/HUP0302940A3/hu unknown
- 2001-07-16 US US09/906,251 patent/US20020107283A1/en not_active Abandoned
- 2001-07-16 AU AU7349301A patent/AU7349301A/xx active Pending
- 2001-07-16 PT PT01952773T patent/PT1305082E/pt unknown
- 2001-07-16 MX MXPA03000619A patent/MXPA03000619A/es active IP Right Grant
- 2001-07-16 EA EA200300042A patent/EA005648B1/ru not_active IP Right Cessation
- 2001-07-16 BR BR0112713-6A patent/BR0112713A/pt not_active Application Discontinuation
- 2001-07-16 AU AU2001273493A patent/AU2001273493B2/en not_active Ceased
- 2001-07-16 CN CNB01815798XA patent/CN1250213C/zh not_active Expired - Fee Related
- 2001-07-16 DK DK01952773T patent/DK1305082T3/da active
- 2001-07-16 ES ES01952773T patent/ES2221651T3/es not_active Expired - Lifetime
- 2001-07-16 EP EP01952773A patent/EP1305082B1/en not_active Expired - Lifetime
- 2001-07-16 WO PCT/US2001/022322 patent/WO2002007822A2/en not_active Ceased
- 2001-07-16 KR KR1020037000914A patent/KR100792814B1/ko not_active Expired - Lifetime
- 2001-07-16 CA CA2416819A patent/CA2416819C/en not_active Expired - Fee Related
- 2001-07-16 SK SK196-2003A patent/SK1962003A3/sk unknown
- 2001-07-16 JP JP2002513552A patent/JP5271473B2/ja not_active Expired - Lifetime
- 2001-07-16 AT AT01952773T patent/ATE267629T1/de not_active IP Right Cessation
- 2001-07-16 PL PL01365701A patent/PL365701A1/xx not_active Application Discontinuation
- 2001-07-16 TR TR2004/01511T patent/TR200401511T4/xx unknown
- 2001-07-16 IL IL15405201A patent/IL154052A0/xx unknown
- 2001-07-16 NZ NZ523851A patent/NZ523851A/en unknown
- 2001-07-20 MY MYPI20013443 patent/MY127317A/en unknown
2003
- 2003-01-20 NO NO20030299A patent/NO330055B1/no not_active IP Right Cessation
- 2003-01-20 IL IL154052A patent/IL154052A/en unknown
- 2003-02-05 BG BG107529A patent/BG107529A/bg unknown
- 2003-02-20 ZA ZA200301403A patent/ZA200301403B/en unknown
2004
- 2004-06-15 US US10/868,633 patent/US20040266866A1/en not_active Abandoned
2005
- 2005-02-18 US US11/194,876 patent/US20060183795A1/en not_active Abandoned
2009
- 2009-07-20 US US12/505,765 patent/US20090281179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL154052A0 (en)	2003-07-31
CN1250213C (zh)	2006-04-12
PL365701A1 (en)	2005-01-10
US20060183795A1 (en)	2006-08-17
JP2004504362A (ja)	2004-02-12
US20040266866A1 (en)	2004-12-30
CN1458853A (zh)	2003-11-26
ZA200301403B (en)	2004-06-15
DK1305082T3 (da)	2004-09-13
AU7349301A (en)	2002-02-05
WO2002007822A3 (en)	2002-05-30
KR100792814B1 (ko)	2008-01-14
MY127317A (en)	2006-11-30
EA200300042A1 (ru)	2003-06-26
SK1962003A3 (en)	2004-08-03
HUP0302940A3 (en)	2012-02-28
CZ2003445A3 (cs)	2004-08-18
MXPA03000619A (es)	2004-07-30
CA2416819A1 (en)	2002-01-31
KR20030022300A (ko)	2003-03-15
BG107529A (bg)	2003-09-30
NO330055B1 (no)	2011-02-14
UA74195C2 (uk)	2005-11-15
DE60103546D1 (de)	2004-07-01
IL154052A (en)	2008-07-08
ES2221651T3 (es)	2005-01-01
JP5271473B2 (ja)	2013-08-21
DE60103546T2 (de)	2005-06-09
EA005648B1 (ru)	2005-04-28
EP1305082B1 (en)	2004-05-26
NO20030299D0 (no)	2003-01-20
WO2002007822A2 (en)	2002-01-31
NO20030299L (no)	2003-03-12
EP1305082A2 (en)	2003-05-02
US20020107283A1 (en)	2002-08-08
TR200401511T4 (tr)	2004-08-23
US20090281179A1 (en)	2009-11-12
HUP0302940A2 (hu)	2003-12-29
CA2416819C (en)	2011-03-22
ATE267629T1 (de)	2004-06-15
NZ523851A (en)	2004-09-24
BR0112713A (pt)	2003-07-22
AU2001273493B2 (en)	2005-08-11

Publication	Publication Date	Title
YU67703A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY133370A (en)	2007-11-30	Carbamate compounds for use in preventing or treating bipolar disorders
PT1408953E (pt)	2006-07-31	Compostos carbamato para utilizacao na prevencao ou tratamento do disturbio bipolar
PT1305082E (pt)	2004-09-30	Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
PT1399144E (pt)	2006-07-31	Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedade
NO20040176L (no)	2004-03-12	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
PL368112A1 (en)	2005-03-21	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en)	2009-01-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en)	2008-09-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain